MedGenome, a San Francisco, CA-based provider of genomic diagnostics for oncology in India and a provider of oncological bioinformatics to the West, raised a $4m Series A funding.
The round was led by Papillon Capital‘s Kartik Kumaramangalam and Emerge Venture‘s Mahesh Pratapneni. Other investors included Dmitri Mehlhorn, former president of Bloomberg BNA Legal; Ambiga Dhiraj, co-founder of MuSigma; Tim McLaughlin, CEO of Siteworx; and Dan Peterson, former CEO of CASHNet. Mehlhorn and MuSigma CEO Dhiraj Rajaram will join MedGenome’s Board of Directors.
The company intends to use the funds to expand R&D and extend its offerings.
Led by Sam Santhosh, chairman and CEO, MedGenome uses DNA sequencing and sophisticated data analytics to advance the fields of genomic oncology and personalized medicine.
OncoMD is a proprietary bioinformatics database of more than 1.2m cancer-related mutations.
MedGenome was incubated from SciGenom in 2012 and is led by Santhosh (former CEO of California Software), COO Dr. VL Ramprasad, Dr. Amitabh Chaudhary, and Dr. Ravi Gupta.
FinSMEs
04/06/2014